REPORTS

Let’s Pullulate and Expand Your Business

Angiotensin Receptor Blockers (ARBs) Market - Global Professional Analysis and Forecast to 2026

Feb 26, 2020  |  201 PAGES  |  REPORT CODE: CMM268802
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Angiotensin Receptor Blockers (ARBs) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.0% during the forecast period.

This report presents the market size and development trends by detailing the Angiotensin Receptor Blockers (ARBs) market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Angiotensin Receptor Blockers (ARBs) market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Angiotensin Receptor Blockers (ARBs) industry and will help you to build a panoramic view of the industrial development.

Angiotensin Receptor Blockers (ARBs) Market, By Type:

  • Valsartan

  • Telmisartan

  • Losartan

  • Irbesartan

  • Azilsartan

  • Olmesartan

Angiotensin Receptor Blockers (ARBs) Market, By Application:

  • Hypertension

  • Cardiovascular Diseases

  • Kidney Diseases

  • Other

Some of the leading players are as follows:

  • Bayer

  • Novartis

  • Eli Lilly

  • Astra Zeneca

  • Teva Pharmaceutical

  • Bristol-Myers Squibb

  • Merck

  • Jhonson and Johnson

  • Sanofi

  • Pfizer

  • GSK

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Angiotensin Receptor Blockers (ARBs) Market: Technology Type Analysis

  • 4.1 Angiotensin Receptor Blockers (ARBs) Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Angiotensin Receptor Blockers (ARBs) Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Valsartan

    • 4.3.2 Telmisartan

    • 4.3.3 Losartan

    • 4.3.4 Irbesartan

    • 4.3.5 Azilsartan

    • 4.3.6 Olmesartan

5 Angiotensin Receptor Blockers (ARBs) Market: Product Analysis

  • 5.1 Angiotensin Receptor Blockers (ARBs) Product Market Share Analysis, 2018 & 2026

  • 5.2 Angiotensin Receptor Blockers (ARBs) Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Angiotensin Receptor Blockers (ARBs) Market: Application Analysis

  • 6.1 Angiotensin Receptor Blockers (ARBs) Application Market Share Analysis, 2018 & 2026

  • 6.2 Angiotensin Receptor Blockers (ARBs) Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hypertension

    • 6.3.2 Cardiovascular Diseases

    • 6.3.3 Kidney Diseases

    • 6.3.4 Other

7 Angiotensin Receptor Blockers (ARBs) Market: Regional Analysis

  • 7.1 Angiotensin Receptor Blockers (ARBs) Regional Market Share Analysis, 2018 & 2026

  • 7.2 Angiotensin Receptor Blockers (ARBs) Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Bayer

    • 9.1.1 Bayer Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Novartis

    • 9.2.1 Novartis Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Eli Lilly

    • 9.3.1 Eli Lilly Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Astra Zeneca

    • 9.4.1 Astra Zeneca Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Teva Pharmaceutical

    • 9.5.1 Teva Pharmaceutical Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Bristol-Myers Squibb

    • 9.6.1 Bristol-Myers Squibb Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Merck

    • 9.7.1 Merck Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Jhonson and Johnson

    • 9.8.1 Jhonson and Johnson Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Sanofi

    • 9.9.1 Sanofi Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Pfizer

    • 9.10.1 Pfizer Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 GSK

    • 9.11.1 GSK Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

 

The List of Tables and Figures (Totals 82 Figures and 160 Tables)

  • Figure Valsartan Angiotensin Receptor Blockers (ARBs) market, 2015 - 2026 (USD Million)

  • Figure Telmisartan Angiotensin Receptor Blockers (ARBs) market, 2015 - 2026 (USD Million)

  • Figure Losartan Angiotensin Receptor Blockers (ARBs) market, 2015 - 2026 (USD Million)

  • Figure Irbesartan Angiotensin Receptor Blockers (ARBs) market, 2015 - 2026 (USD Million)

  • Figure Azilsartan Angiotensin Receptor Blockers (ARBs) market, 2015 - 2026 (USD Million)

  • Figure Olmesartan Angiotensin Receptor Blockers (ARBs) market, 2015 - 2026 (USD Million)

  • Figure Hypertension market, 2015 - 2026 (USD Million)

  • Figure Cardiovascular Diseases market, 2015 - 2026 (USD Million)

  • Figure Kidney Diseases market, 2015 - 2026 (USD Million)

  • Figure Other market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Angiotensin Receptor Blockers (ARBs) market, by country, 2015 - 2026 (USD Million)

  • Table North America Angiotensin Receptor Blockers (ARBs) market, by type, 2015 - 2026 (USD Million)

  • Table North America Angiotensin Receptor Blockers (ARBs) market, by product, 2015 - 2026 (USD Million)

  • Table North America Angiotensin Receptor Blockers (ARBs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Angiotensin Receptor Blockers (ARBs) market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Angiotensin Receptor Blockers (ARBs) market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Angiotensin Receptor Blockers (ARBs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Angiotensin Receptor Blockers (ARBs) market, by type, 2015 - 2026 (USD Million)

  • Table Canada Angiotensin Receptor Blockers (ARBs) market, by product, 2015 - 2026 (USD Million)

  • Table Canada Angiotensin Receptor Blockers (ARBs) market, by application, 2015 - 2026 (USD Million)

  • Table Europe Angiotensin Receptor Blockers (ARBs) market, by country, 2015 - 2026 (USD Million)

  • Table Europe Angiotensin Receptor Blockers (ARBs) market, by type, 2015 - 2026 (USD Million)

  • Table Europe Angiotensin Receptor Blockers (ARBs) market, by product, 2015 - 2026 (USD Million)

  • Table Europe Angiotensin Receptor Blockers (ARBs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Angiotensin Receptor Blockers (ARBs) market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Angiotensin Receptor Blockers (ARBs) market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Angiotensin Receptor Blockers (ARBs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Angiotensin Receptor Blockers (ARBs) market, by type, 2015 - 2026 (USD Million)

  • Table Germany Angiotensin Receptor Blockers (ARBs) market, by product, 2015 - 2026 (USD Million)

  • Table Germany Angiotensin Receptor Blockers (ARBs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Angiotensin Receptor Blockers (ARBs) market, by type, 2015 - 2026 (USD Million)

  • Table France Angiotensin Receptor Blockers (ARBs) market, by product, 2015 - 2026 (USD Million)

  • Table France Angiotensin Receptor Blockers (ARBs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Angiotensin Receptor Blockers (ARBs) market, by type, 2015 - 2026 (USD Million)

  • Table Italy Angiotensin Receptor Blockers (ARBs) market, by product, 2015 - 2026 (USD Million)

  • Table Italy Angiotensin Receptor Blockers (ARBs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Angiotensin Receptor Blockers (ARBs) market, by type, 2015 - 2026 (USD Million)

  • Table Spain Angiotensin Receptor Blockers (ARBs) market, by product, 2015 - 2026 (USD Million)

  • Table Spain Angiotensin Receptor Blockers (ARBs) market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Angiotensin Receptor Blockers (ARBs) market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Angiotensin Receptor Blockers (ARBs) market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Angiotensin Receptor Blockers (ARBs) market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Angiotensin Receptor Blockers (ARBs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Angiotensin Receptor Blockers (ARBs) market, by type, 2015 - 2026 (USD Million)

  • Table China Angiotensin Receptor Blockers (ARBs) market, by product, 2015 - 2026 (USD Million)

  • Table China Angiotensin Receptor Blockers (ARBs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Angiotensin Receptor Blockers (ARBs) market, by type, 2015 - 2026 (USD Million)

  • Table Japan Angiotensin Receptor Blockers (ARBs) market, by product, 2015 - 2026 (USD Million)

  • Table Japan Angiotensin Receptor Blockers (ARBs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Angiotensin Receptor Blockers (ARBs) market, by type, 2015 - 2026 (USD Million)

  • Table India Angiotensin Receptor Blockers (ARBs) market, by product, 2015 - 2026 (USD Million)

  • Table India Angiotensin Receptor Blockers (ARBs) market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Angiotensin Receptor Blockers (ARBs) market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Angiotensin Receptor Blockers (ARBs) market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Angiotensin Receptor Blockers (ARBs) market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Angiotensin Receptor Blockers (ARBs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Angiotensin Receptor Blockers (ARBs) market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Angiotensin Receptor Blockers (ARBs) market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Angiotensin Receptor Blockers (ARBs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Angiotensin Receptor Blockers (ARBs) market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Angiotensin Receptor Blockers (ARBs) market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Angiotensin Receptor Blockers (ARBs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Angiotensin Receptor Blockers (ARBs) market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Angiotensin Receptor Blockers (ARBs) market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Angiotensin Receptor Blockers (ARBs) market, by application, 2015 - 2026 (USD Million)

  • Table MEA Angiotensin Receptor Blockers (ARBs) market, by country, 2015 - 2026 (USD Million)

  • Table MEA Angiotensin Receptor Blockers (ARBs) market, by type, 2015 - 2026 (USD Million)

  • Table MEA Angiotensin Receptor Blockers (ARBs) market, by product, 2015 - 2026 (USD Million)

  • Table MEA Angiotensin Receptor Blockers (ARBs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Angiotensin Receptor Blockers (ARBs) market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Angiotensin Receptor Blockers (ARBs) market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Angiotensin Receptor Blockers (ARBs) market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Angiotensin Receptor Blockers (ARBs) market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Angiotensin Receptor Blockers (ARBs) market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Angiotensin Receptor Blockers (ARBs) market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Bayer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eli Lilly Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Astra Zeneca Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Teva Pharmaceutical Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bristol-Myers Squibb Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Jhonson and Johnson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GSK Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top